Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $1,749,796.30 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 3,031 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total transaction of $1,749,796.30. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $203,786.90. This represents a 89.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Thursday, February 27th, Myriam Curet sold 2,401 shares of Intuitive Surgical stock. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00.
• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $568.02 on Thursday. The firm has a market cap of $202.32 billion, a PE ratio of 88.61, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a 50 day moving average price of $571.70 and a 200-day moving average price of $530.90.

Institutional Trading of Intuitive Surgical

A number of institutional investors have recently made changes to their positions in the stock. Siemens Fonds Invest GmbH boosted its stake in shares of Intuitive Surgical by 795.2% during the fourth quarter. Siemens Fonds Invest GmbH now owns 143,818 shares of the medical equipment provider’s stock valued at $75,067,000 after purchasing an additional 127,753 shares during the period. BridgePort Financial Solutions LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $330,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $167,943,000. Employees Retirement System of Texas boosted its stake in shares of Intuitive Surgical by 16.2% during the fourth quarter. Employees Retirement System of Texas now owns 8,346 shares of the medical equipment provider’s stock valued at $4,356,000 after purchasing an additional 1,165 shares during the period. Finally, Brucke Financial Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $208,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on ISRG. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.